Avidity biosciences announces upcoming presentations at 28th annual congress of the world muscle society

San diego , sept. 26, 2023 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that the company will be presenting one oral and six poster presentations at the 28th annual congress of the world muscle society (wms), being held october 3-7, 2023, in charleston, south carolina.
RNA Ratings Summary
RNA Quant Ranking